Researchers in South Africa have identified how the protein Mucin-1 shifts from protective sentinel to cancer enabler. The finding may open new directions in oncology research.
A protein that lines the body's organs has long been understood as a first line of defence. New research suggests it can also work against the body.
Scientists in South Africa have been studying Mucin-1 (MUC1), a protein found on the surface of cells that line organs including the breast, colon, and lungs, according to a report published by The Conversation Africa. In a healthy body, the researchers describe MUC1 as functioning like a sentinel — maintaining the epithelial barrier that protects tissue from external threats.
The study found that in cancerous conditions, MUC1 undergoes a structural shift that allows tumours to exploit it. Rather than defending the cell, the altered protein appears to help cancer evade immune detection, according to the researchers. The team described this as one of cancer's most effective survival mechanisms.
The South African scientists, writing via The Conversation Africa, reported that understanding this switch could provide a clearer target for therapeutic intervention. The research adds to a growing body of work examining how proteins with protective functions are co-opted by malignant cells.
For the albinism community, the relevance is direct. People with albinism produce reduced or absent melanin, which limits the skin's primary defence against ultraviolet radiation. Skin cancer rates among people with albinism — particularly in Sub-Saharan Africa — are significantly elevated compared to the general population, according to data cited by the Albinism Foundation of East Africa. Research that advances understanding of how cancer establishes and sustains itself carries weight for a community that faces higher lifetime exposure to UV-related cellular damage.
The Conversation Africa noted that the South African team's work is at an early, foundational stage. No clinical applications were announced. The researchers indicated the findings would inform further investigation into how MUC1's behaviour might be interrupted before tumour protection is established.
Cancer biology moves slowly from the laboratory to the clinic. This particular finding, specific and structural, is one step in that process.
Keywords
Core topics and entities mentioned in this summary.